Komori
Delta-Fly Pharma (4598) · PolicyRestated

Adoption of the Revenue Recognition Standard

First written in FY2022-Q1. 2 of 3 entries say "Restated". Latest entry: FY2022-Q3.

3entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2022-Q1 – FY2022-Q32021: 220212022: 12022
Same theme, other companies

The whole theme swung hardest in 2020: 1 of 11 companies on the "Worse" side.

94 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 127 companies compared. The sentences above are computed from all 127.
Full recordFilings, disclosures and news, newest first
  1. FY2022-Q3RestatedAnnual report

    「The “Accounting Standard for Revenue Recognition” (Accounting Standard No. 29, 31 March 2020; hereinafter, the “Revenue Recognition Accounting Standard”) and other standards were applied from the beginning of the first quarter accounting period. Revenue is recognized at the amount expected to be received in exchange for the promised goods or services when control of those goods or services is transferred to the customer.」

    第1四半期会計期間の期首から収益認識会計基準等を適用する会計方針を継続している。
  2. FY2022-Q2RestatedAnnual report

    「The “Accounting Standard for Revenue Recognition” (Accounting Standard No. 29, 31 March 2020; hereinafter, the “Revenue Recognition Accounting Standard”) and other standards were applied from the beginning of the first quarter accounting period. Revenue is recognized at the amount expected to be received in exchange for the promised goods or services when control of those goods or services is transferred to the customer.」

    The Company continues to apply the revenue recognition accounting standards and related standards from the beginning of the first quarter accounting period.
  3. FY2022-Q1First statedAnnual report

    「We applied the Accounting Standard for Revenue Recognition (ASBJ Statement No. 29, dated 31 March 2020) and related standards from the beginning of the first quarter, and began recognizing revenue at the time control of the promised goods or services transfers to the customer, at the amount expected to be received in exchange for those goods or services.」

    当第1四半期会計期間の期首から収益認識会計基準等を適用し、顧客への支配移転時点で収益を認識する会計方針を導入した。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Delta-Fly Pharma yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.